Pyxis Oncology earnings were -$96.3M for the trailing 12 months ending Jun 30, 2025, with N/A growth year over year. The latest PYXS earnings report on Jun 30, 2025 announced Q2 2025 earnings of -$18.4M, down 13.3% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, PYXS reported annual earnings of -$77.3M, with 4.8% growth.
On PYXS's earnings call on Invalid Date, Pyxis Oncology (NASDAQ: PYXS) reported Q2 2025 earnings per share (EPS) of -$0.30, up 3.45% year over year. Total PYXS earnings for the quarter were -$18.35 million. In the same quarter last year, Pyxis Oncology's earnings per share (EPS) was -$0.29.
As of the last Pyxis Oncology earnings report, Pyxis Oncology is currently losing money. Pyxis Oncology's net profit (also called net income) for the twelve months ending Jun 30, 2025 was -$96.29 million, a 62.64% increase year over year.
What was PYXS's earnings growth in the past year?
As of Pyxis Oncology's earnings date in Invalid Date, Pyxis Oncology's earnings has grown year over year. PYXS earnings in the past year totalled -$96.29 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.